首页> 美国卫生研究院文献>Nature Public Health Emergency Collection >Clinical study on the related markers of blood coagulation in the patients with ANFH after SARS
【2h】

Clinical study on the related markers of blood coagulation in the patients with ANFH after SARS

机译:SARS后ANFH患者凝血相关指标的临床研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The aim of this research was to investigate the blood coagulation function in the patients with avascular necrosis of the femoral head (ANFH) after severe acute respiratory syndrome (SARS). The expression of CD31, CD61, CD62p, CD63 and PAC-1 on platelet membrane was measured respectively by flowcytometry, and the plasma prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT) and fibrinogen (Fbg) were measured by blood clotting instrument in 26 patients with ANFH after SARS and in 17 healthy adults. The expression of CD31, CD61, CD 62p, CD63 and PAC-1 on platelet membrane in 26 patients was all lower than that in 17 healthy subjects ( < 0.01). The levels of PT, APTT, TT and Fbg in 26 patients were all normal. There is no significant difference ( > 0.05) in those markers between patients and 17 healthy adults. The blood may not be in hypercoagulable state in patients with ANFH after SARS.
机译:这项研究的目的是调查严重急性呼吸系统综合症(SARS)后股骨头缺血性坏死(ANFH)患者的凝血功能。用流式细胞术分别检测血小板膜上CD31,CD61,CD62p,CD63p和PAC-1的表达,并测定血浆凝血酶原时间(PT),活化部分凝血活酶时间(APTT),凝血酶时间(TT)和纤维蛋白原(Fbg)通过血液凝结仪对26例SARS后的ANFH患者和17例健康成年人进行了测量。 26例患者血小板膜上CD31,CD61,CD 62p,CD63和PAC-1的表达均低于17例健康人(<0.01)。 26例患者的PT,APTT,TT和Fbg水平均正常。患者和17位健康成年人之间的这些标记物无显着差异(> 0.05)。 SARS后ANFH患者的血液可能未处于高凝状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号